[go: up one dir, main page]

BR0209054A - Arilsulfonamidas como agentes antivirais - Google Patents

Arilsulfonamidas como agentes antivirais

Info

Publication number
BR0209054A
BR0209054A BR0209054-6A BR0209054A BR0209054A BR 0209054 A BR0209054 A BR 0209054A BR 0209054 A BR0209054 A BR 0209054A BR 0209054 A BR0209054 A BR 0209054A
Authority
BR
Brazil
Prior art keywords
arylsulfonamides
antiviral agents
well
arylulphonamides
substituents
Prior art date
Application number
BR0209054-6A
Other languages
English (en)
Inventor
Tobias Wunberg
Wolfgang Bender
Peter Eckenberg
Sabine Hallenberger
Kerstin Henninger
Joerg Keldenich
Armin Kern
Siegfried Raddatz
Juergen Reefschlaeger
Gunter Schmidt
Holger Zimmermann
Franz Zumpe
Martin Radtke
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10148598A external-priority patent/DE10148598A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BR0209054A publication Critical patent/BR0209054A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

"ARILSULFONAMIDAS COMO AGENTES ANTIVIRAIS". A presente invenção refere-se a novas sulfonamidas da fórmula geral (I), na qual os substituintes R^ 1^, R^ 2^, R^ 3^, R^ 4^ bem como A e X têm os significados indicados, bem como processos para a sua preparação e sua aplicação como composições antivirais, especialmente contra citomegalovírus.
BR0209054-6A 2001-04-19 2002-04-08 Arilsulfonamidas como agentes antivirais BR0209054A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10119137 2001-04-19
DE10148598A DE10148598A1 (de) 2001-04-19 2001-10-02 Neue Arylsulfonamide als antivirale Mittel
PCT/EP2002/003858 WO2002085869A1 (de) 2001-04-19 2002-04-08 Arylsulfonamide als antivirale mittel

Publications (1)

Publication Number Publication Date
BR0209054A true BR0209054A (pt) 2004-04-20

Family

ID=26009118

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0209054-6A BR0209054A (pt) 2001-04-19 2002-04-08 Arilsulfonamidas como agentes antivirais

Country Status (20)

Country Link
US (1) US7115612B2 (pt)
EP (1) EP1383749B1 (pt)
JP (1) JP4480941B2 (pt)
CN (1) CN1516695A (pt)
AT (1) ATE308529T1 (pt)
BG (1) BG108272A (pt)
BR (1) BR0209054A (pt)
CA (1) CA2444123C (pt)
DE (1) DE50204780D1 (pt)
EE (1) EE200300515A (pt)
ES (1) ES2252455T3 (pt)
HU (1) HUP0303813A3 (pt)
IL (1) IL158324A0 (pt)
MX (1) MXPA03009548A (pt)
NO (1) NO20034667L (pt)
PL (1) PL363990A1 (pt)
RU (1) RU2003133750A (pt)
SK (1) SK12662003A3 (pt)
UY (1) UY27263A1 (pt)
WO (1) WO2002085869A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20050168A2 (en) * 2002-08-23 2005-10-31 Rigel Pharmaceuticals Pyridyl substituted heterocycles useful for treating or preventing hcv infection
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
ES2770035T3 (es) 2003-04-11 2020-06-30 Ptc Therapeutics Inc Compuesto de ácido 1,2,4-oxadiazol benzoico y su uso para la supresión sin sentido y el tratamiento de enfermedades
DE102006009928A1 (de) * 2006-03-03 2007-09-06 Aicuris Gmbh & Co. Kg Substituierte Arylsulfonamide
WO2007117438A2 (en) 2006-03-30 2007-10-18 Ptc Therapeutics, Inc. Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
JP2010531850A (ja) * 2007-07-02 2010-09-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規化合物
EP2177521A1 (en) * 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
EP2202232A1 (en) * 2008-12-26 2010-06-30 Laboratorios Almirall, S.A. 1,2,4-oxadiazole derivatives and their therapeutic use
RU2013103422A (ru) * 2010-06-28 2014-08-10 Байер Интеллектчуал Проперти Гмбх Гетероарил-замещенные пиридиновые соединения для применения в качестве пестицидов
EP2593434A1 (en) 2010-07-16 2013-05-22 Purdue Pharma LP Pyridine compounds as sodium channel blockers
WO2013136170A1 (en) 2012-03-16 2013-09-19 Purdue Pharma L.P. Substituted pyridines as sodium channel blockers
US9334249B2 (en) 2012-11-03 2016-05-10 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
WO2014070978A1 (en) * 2012-11-03 2014-05-08 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
US9714252B2 (en) 2012-12-20 2017-07-25 Purdue Pharma L.P. Cyclic sulfonamides as sodium channel blockers
CA2942147C (en) 2014-03-06 2022-12-13 Ptc Therapeutics, Inc. Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
WO2016128541A1 (en) * 2015-02-13 2016-08-18 Azienda Ospedaliera Universitaria Senese Human helicase ddx3 inhibitors as therapeutic agents
CN108348527A (zh) 2015-10-30 2018-07-31 Ptc医疗公司 用于治疗癫痫的方法
SG11201909079PA (en) * 2017-03-31 2019-10-30 Perenna Pharmaceuticals Inc Compounds useful as inhibitors of alcat 1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (de) * 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
WO2000063194A1 (en) * 1999-04-19 2000-10-26 Shionogi & Co., Ltd. Sulfonamide derivatives having oxadiazole rings

Also Published As

Publication number Publication date
BG108272A (bg) 2004-10-29
PL363990A1 (en) 2004-11-29
CA2444123A1 (en) 2002-10-31
ATE308529T1 (de) 2005-11-15
EP1383749B1 (de) 2005-11-02
ES2252455T3 (es) 2006-05-16
SK12662003A3 (sk) 2004-04-06
IL158324A0 (en) 2004-05-12
WO2002085869A1 (de) 2002-10-31
CN1516695A (zh) 2004-07-28
DE50204780D1 (de) 2005-12-08
MXPA03009548A (es) 2004-05-24
UY27263A1 (es) 2002-11-29
US7115612B2 (en) 2006-10-03
NO20034667D0 (no) 2003-10-17
CA2444123C (en) 2010-09-21
EE200300515A (et) 2004-02-16
JP2004531536A (ja) 2004-10-14
HUP0303813A2 (hu) 2004-03-29
RU2003133750A (ru) 2005-05-10
NO20034667L (no) 2003-12-12
US20040176374A1 (en) 2004-09-09
JP4480941B2 (ja) 2010-06-16
HUP0303813A3 (en) 2005-05-30
EP1383749A1 (de) 2004-01-28

Similar Documents

Publication Publication Date Title
BR0209054A (pt) Arilsulfonamidas como agentes antivirais
BR0211482A (pt) Pirazolilcarboxanilidas como fungicidas
BR0314087A (pt) Cetoenóis spirocìclicos substituìdos
BR0112676A (pt) Bifenilcarboxamidas
BR0110824A (pt) Iminoazinas substituìdas
BRPI0411916A (pt) imidazoquinolinas substituìdas por sulfonamida
BR0307599A (pt) Derivados de sulfonilamino como inibidores de histona deacetilase
BRPI0408347A (pt) derivados de pirimidina
BRPI0407145A (pt) Pirazolilcarboxanilidas para combater microorganismos indesejados
DK1483245T3 (da) 5-substituerede alkylaminopyrazolderivater som pesticider
BR9911978A (pt) Feniluracilas substituìdas
BR0208534A (pt) Processo para preparação de 4,6-diaminopirimido[5,4-d]pirimidinas
BR9915260A (pt) Enaminonas cìclicas substituìdas por fenila
BR9909548A (pt) Fenilpiridazinonas substituìdas
BR0109054A (pt) Benzoilciclohexenonas substituìdas
BR0112043A (pt) Ftalidas substituìdas, processo para sua preparação e composições farmacêuticas contendo-as
NO20045063L (no) Preparater inneholdende minst ett diformat
BR0209537A (pt) Arilcetonas substituìdas
BR0309568A (pt) Triazolopirimidinas
BR0313751A (pt) Heterociclilpirimidinas substituìdas
BRPI0512580A (pt) derivados de n-fenilpirazol como pesticidas
BR0013084A (pt) Heterociclil-2h-cromenos substituìdos
DK0745081T3 (da) Indan-2-mercaptoacetylamiddisulfidderivater, der er anvendelige som enkephalinase-inhibitorer
BR0211337A (pt) Derivados de pirazolina e sua aplicação como composições praguicidas
BRPI0406804A (pt) 4-cetolactamas e -lactonas trussubstituìdas substituìdas por 3-fenila

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A E 7A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2029 DE 24/11/2009.